KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Net Margin (2016 - 2025)

Historic Net Margin for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to 7.6%.

  • Quest Diagnostics' Net Margin fell 4000.0% to 7.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.78%, marking a year-over-year increase of 1800.0%. This contributed to the annual value of 8.78% for FY2024, which is 3700.0% down from last year.
  • As of Q3 2025, Quest Diagnostics' Net Margin stood at 7.6%, which was down 4000.0% from 9.05% recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Net Margin registered a high of 23.49% during Q2 2021, and its lowest value of 3.26% during Q4 2022.
  • For the 5-year period, Quest Diagnostics' Net Margin averaged around 9.86%, with its median value being 8.41% (2023).
  • As far as peak fluctuations go, Quest Diagnostics' Net Margin skyrocketed by 262300bps in 2021, and later crashed by -150500bps in 2022.
  • Over the past 5 years, Quest Diagnostics' Net Margin (Quarter) stood at 12.72% in 2021, then plummeted by -74bps to 3.26% in 2022, then skyrocketed by 117bps to 7.08% in 2023, then grew by 6bps to 7.48% in 2024, then rose by 2bps to 7.6% in 2025.
  • Its Net Margin stands at 7.6% for Q3 2025, versus 9.05% for Q2 2025 and 6.94% for Q1 2025.